TNFRSF14 (CT) Blocking Peptide
TNFRSF14 (CT) Blocking Peptide
Product No.: T329
[product_table name="All Top" skus="T329"]
- -
- -
| Target Tumor Necrosis Factor Receptor Superfamily Member 14 Product Type Blocking Peptide Alternate Names Herpesvirus Entry Mediator (HVEM), TR2, ATAR, HVEA, LIGHTR |
- -
- -
| Select Product Size | Qty Max: Min: 1 Step: 1 $110.00 |
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Product Concentration 0.2 mg/ml Amino Acid Location 16 amino acids near the carboxy terminus of human TNFRSF14. Formulation This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Storage and Handling Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day Ambient Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionBackground Tumor necrosis factor receptor superfamily member 14 (herpesvirus entry mediator), also known as TNFRSF14, is the cellular receptor for TNF superfamily 14 (LIGHT).1 TNFRSF14 is a type I membrane protein that is considered as a Herpesvirus entry mediator.2 It is able to inhibit the proliferation, activation, and cytokine production of T cells. TNFRSF14 is expressed by peripheral blood T cells, B cells, monocytes and in various tissues enriched in lymphoid cells. References & Citations1. Park JE et al. (2001) Arterioscler Thromb Vasc Biol. 21: 1873
2. Montgomery RI et al. (1996) Cell 87: 427
|
Related Products
- -
- -
Prod No. | Description |
|---|---|
| T330 | |
| T329 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
